| 18/04/2024 |
10:05 to 11:15 |
Golden Hall |
Prostate Module - Metastatic Disease Session |
10:05 to 10:20 |
Management of metastatic castration-sensitive prostate cancer |
Speaker |
| 18/04/2024 |
10:05 to 11:15 |
Golden Hall |
Prostate Module - Metastatic Disease Session |
10:20 to 10:25 |
Discussion |
Discussant |
| 18/04/2024 |
11:15 to 11:55 |
Golden Hall |
Clinical cases: metastatic castration-sensitive prostate cancer |
|
|
Discussant |
| 18/04/2024 |
15:15 to 15:55 |
Golden Hall |
Clinical cases: metastatic castration-resistant prostate cancer |
|
|
Discussant |
| 19/04/2024 |
12:05 to 12:45 |
Golden Hall |
Clinical cases: bladder cancer - muscle-invasive disease |
|
|
Discussant |
| 19/04/2024 |
14:05 to 15:05 |
Golden Hall |
Bladder Module - Metastatic Disease Session |
14:05 to 14:35 |
First-line treatment of metastatic bladder cancer: state of the art |
Speaker |
| 19/04/2024 |
14:05 to 15:05 |
Golden Hall |
Bladder Module - Metastatic Disease Session |
14:35 to 14:40 |
Discussion |
Discussant |
| 19/04/2024 |
15:45 to 16:05 |
Golden Hall |
Bladder Module - Metastatic Disease Session |
15:45 to 16:00 |
Treatment of upper tract urothelial cancer: state of the art
|
Speaker |
| 19/04/2024 |
15:45 to 16:05 |
Golden Hall |
Bladder Module - Metastatic Disease Session |
16:00 to 16:05 |
Discussion |
Discussant |
| 19/04/2024 |
17:35 to 18:05 |
Golden Hall |
Clinical cases: metastatic urothelial cancer (session 1) |
|
|
Discussant |
| 19/04/2024 |
19:05 to 19:35 |
Golden Hall |
Clinical cases: metastatic urothelial cancer (session 2) |
|
|
Discussant |
